Pharmaceutical Manufacturing & Methods
Category VIEW ALL
Solid particles of RNA lipid nanoparticles
Technology No. 2025-ZHOU-71178
Protein solids
Technology No. 2025-ZHOU-71177
Discovery of highly potent HIV-1 protease inhibitors with polycyclic-THF ligands
Technology No. 2020-GHOS-68891
Highly Efficient and Optically Active Synthesis of bis-THF Ligand of Darunavir
Technology No. 2020-GHOS-68848
Liposome Formulation with High Drug Capacity
Technology No. 2019-YEO-68485
Rapid Purification of Biopharmaceuticals by Crystallization
Technology No. 2019-NAGY-68435
Suspension-based Oral Solid Doses
Technology No. 2018-REKL-68230
Application of Sequential Palladium Catalysis for the Discovery of Janus Kinase Inhibitors
Technology No. 2018-CUSH-68109
Albumin-coated Nanocrystals
Technology No. 2016-YEO-67581
Enantioselective Total Synthesis of Both Antipodes in the Proposed Structure of Macrolide Cytotoxic Agent Callyspongiolide
Technology No. 2016-GHOS-67560
Anti-Fouling Control of Plug-Flow Crystallization via Heating and Cooling Cycle
Technology No. 2016-KOSW-67539
MiniPharm: Miniaturized Continuous End-to-End Manufacturing of Solid Pharmaceuticals
Technology No. 2015-NAGY-67209
Preparation and Applications of Polyrotaxanes Bearing Mixed Cyclodextrin Species
Technology No. 2015-THOM-67198
Adenylyl Cyclase Inhibitors for Neuropathic and Inflammatory Pain Treatment
Technology No. 2015-DAI-67035
Novel Anticancer Compounds
Technology No. 2014-GHOS-66703
Indenoisoquinoline Topoisomerase I Inhibitors Substituted with Carbohydrates
Technology No. 65707
Vaccine Linkers to Attach Proteins to Aluminum Hydroxide Adjuvants
Technology No. 65683
The Release of Trifluoroacetate and Applications to Synthesis
Technology No. 65561
Affinity Stabilization of Protein Drugs
Technology No. 65558
Bacteriophage formulations
Technology No. 2025-ZHOU-70957
Engineered Polymeric Excipients for Enhancing the Stability of Protein Biologics
Technology No. 2024-WON-70668
Microwave Assisted Catalytic Amidation of Organic Amines with Carboxylic Acids
Technology No. 2024-THOM-70677
mRNA Delivered Cell-surface Targeted and Epitope-focused Glycoprotein Antigens for HCV Vaccine
Technology No. 2024-KUHN-70514
Excipient-Free Lyophilization of Aqueous Polymer Micelle Suspensions
Technology No. 2023-WON-69925
Precision 3D Printing Method for Customizable Pharmaceutical Mini-Tablets
Technology No. 2023-SUND-70094
Cyclic Peptide Stimulators of the Proteasome
Technology No. 2023-PARK-70287
Repurposing Phenol & Phosphate Anticancer Drugs as Cationic Lipid Salts in Solid Lipid Nanoparticles Focused on Etoposide
Technology No. 2023-BYRN-69951
Sequence-Controlled Aliphatic Copolyesters
Technology No. 2022-WON-69547
Continuous Flow Synthesis of Lorazepam
Technology No. 2022-THOM-69904
Continuous Flow Synthesis of A2E
Technology No. 2022-THOM-69651
Polymer Salts for Improved Drug Delivery from Amorphous Solid Dispersions
Technology No. 2022-TAYL-69671
Highly Efficient and Optically Active Synthesis of Crown-THF Ligand
Technology No. 2022-GHOS-69804
Catalysis-Enabled Concise Total Synthesis of the Tricyclic Prostaglandin D2 Metabolite Methyl Ester
Technology No. 2022-DAI-69694
Novel Amination Method for Medicinally Important Compounds
Technology No. 2021-DAI-69172
Mixed Solvent Micelle Formulation Procedure
Technology No. 2020-WON-69093
Telescoped Continuous Flow Synthesis of an Alkynylnaphthyridine Anticancer Agent, HSN608
Technology No. 2020-THOM-69095
Tetrahydro-3H-pyrazolo[4,3-f]quinolone and tetrahydro-3H-pyrrolo[3,2-f]quinoline -Containing Compounds as Anticancer Agents
Technology No. 2020-SINT-69102
![Tetrahydro-3H-pyrazolo[4,3-f]quinolone and tetrahydro-3H-pyrrolo[3,2-f]quinoline -Containing Compounds as Anticancer Agents](https://storage.googleapis.com/elucid3-storage-1-us/uw/product/13208/2/tetrahydro-3h-pyrazolo43-fquinolone-and-tetrahydro-3h-pyrrolo32-fquinoline--containing-compounds-as-anticancer-agents-01.png?mtime=20251202162718)
Crystallization Method to Reduce Filtration Time of Agrochemicals
Technology No. 2020-NAGY-69085
